In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS-CoV-2 main protease (3CLpro)

Phytother Res. 2021 Jun;35(6):2841-2845. doi: 10.1002/ptr.6998. Epub 2021 Jan 15.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents
  • COVID-19*
  • Drug Repositioning
  • Humans
  • Kaempferols / pharmacology
  • Molecular Dynamics Simulation
  • Peptide Hydrolases
  • SARS-CoV-2*

Substances

  • Antiviral Agents
  • Kaempferols
  • Peptide Hydrolases